Skip to main content
Orexo logo

Orexo — Investor Relations & Filings

Ticker · ORX ISIN · SE0000736415 LEI · 549300LJ5CCWDPTK9Z08 ST Manufacturing
Open in API
Filings indexed 843 across all filing types
Latest filing 2009-06-30 Earnings Release
Country SE Sweden
Listing ST ORX

About Orexo

https://orexo.com/

Orexo is a commercial-stage pharmaceutical company focused on developing improved pharmaceuticals and digital therapies. The company addresses unmet patient needs, particularly within substance use disorders and mental health. It leverages proprietary drug delivery and formulation technologies to create innovative treatment solutions. Orexo's activities span research, development, and commercialization of its products.

Recent filings

Filing Released Lang Actions
Earnings Release 2009
Earnings Release Classification · 1% confidence The document is explicitly titled "Press release, June 30, 2009" and announces a specific business event: the readiness for launch of the product Abstral in France following regulatory approval. This type of announcement, detailing operational progress, partnership updates, and market entry, is characteristic of an Earnings Release (ER) or a general regulatory announcement. Since it is a press release announcing operational news rather than a full financial report (10-K, IR) or a specific regulatory filing like insider trading (DIRS) or dividend (DIV), it fits best under the 'Earnings Release' category, which often includes key operational highlights preceding or accompanying formal financial reports. Given the context of a press release announcing a significant business milestone, ER is the most appropriate fit among the provided options, although RNS (Regulatory Filings) is a close secondary option if ER is strictly reserved for quarterly/annual financial summaries. However, press releases detailing key operational achievements are commonly classified as ERs in financial databases. The document length (4351 chars) is substantial enough to be more than just a brief notification of publication (RPA/RNS). FY 2009
2009-06-30 English
Regulatory Filings 2009
Regulatory Filings Classification · 1% confidence The document is titled "Pressmeddelande" (Press Release) and is dated June 30, 2009. It announces a business development event: Orexo's partner, ProStrakan, confirms that pricing negotiations for the drug Abstral in France are complete, allowing for a launch next month. This is a timely announcement regarding business operations, partnership progress, and market entry, rather than a comprehensive financial report (10-K, IR), a formal shareholder vote result (DVA), or a specific regulatory filing like insider trading (DIRS) or capital change (SHA). Since it is a general, time-sensitive announcement about business progress that doesn't fit the specific financial or governance categories, it best aligns with a general Regulatory Filing or Announcement category. Given the options, 'Regulatory Filings' (RNS) is the most appropriate fallback for a general press release announcing operational milestones, especially since it concludes with a note about disclosure obligations under securities law.
2009-06-30 Swedish
Major Shareholding Notification 2009
Major Shareholding Notification Classification · 1% confidence The document explicitly details a change in shareholding for 'Orexo AB' by the holder 'HealthCap'. It specifies the number of shares, the resulting percentage of voting rights, and the reason for the notification ('Sell'). This structure is characteristic of a Major Shareholding Notification, where an entity reports crossing ownership thresholds. This aligns directly with the definition for 'Major Shareholding Notification' (Code: MRQ). The document length is short (1975 chars), but the content is the notification itself, not an announcement of a report, thus MRQ is preferred over RPA/RNS.
2009-05-08 English
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 1% confidence The document is a comprehensive 'delårsrapport' (interim report) for Orexo AB for the period January-March 2009. It contains detailed financial statements (income statement), management commentary (VD:s kommentar), analysis of business trends, and significant events during the quarter. It is clearly a substantive financial report for a period shorter than a full fiscal year, not merely an announcement or a certification. Q1 2009
2009-05-06 Swedish
Interim / Quarterly Report 2009
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim report, January-March 2009' and contains comprehensive financial statements, including a condensed statement of operations, earnings per share data, and detailed management commentary on business performance and key events for the specified period. It is a substantive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. Q1 2009
2009-05-06 English
AGM Information 2009
AGM Information Classification · 1% confidence The document is explicitly titled 'Report from Orexo AB's Annual General Meeting, 23 April 2009'. It details resolutions passed at the meeting, including the approval of financial statements, re-election and election of board members, decisions on director fees, and the adoption of share/option plans. These contents are characteristic of materials presented or summarized following an Annual General Meeting (AGM). Therefore, the appropriate classification is AGM-R (AGM Information).
2009-04-23 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.